Does neoadjuvant chemotherapy provide any benefit for surgical de-escalation in luminal B, HER2(-) breast cancers?

Does neoadjuvant chemotherapy provide any benefit for surgical de-escalation in luminal B, HER2(-) breast cancers?

Aysegul Aktas 1, Meryem Gunay-Gurleyik 1, Fugen Aker 2, Yasar Kaan-Akgok 2, Elif Atag 3

1 Department of General Surgery, Haydarpasa Numune Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey; 2 Department of Pathology, Haydarpasa Numune Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey; 3 Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital. University of Health Sciences Turkey, Istanbul, Turkey

Aysegul Aktas, Meryem Gunay-Gurleyik, Fugen Aker, Yasar Kaan-Akgok, Elif Atag

La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.

*Correspondence: Aysegul Aktas, Email not available

Abstract

Full content available in the PDF

Keywords:  Breast cancer. Neoadjuvant chemotherapy. Pathological complete response. Surgical de-escalation.

Contents

⇄ Versión en Español
DOI: 10.24875/CIRUE.M22000277
Add to Mendeley
    Descargar PDF
    English versión
    DOI: 10.24875/CIRUE.M22000277